Back to
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
ABT26 quarters
Position history for
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in ABBOTT LABORATORIES
Yes. Arrowstreet Capital holds 10,897,178 shares of ABT (Abbott Laboratories), worth $988.8M, as of its Q2 2026 13F filing. It increased the position by 5,374,956 shares (+97.3%) from Q1 2026. Arrowstreet Capital has held ABT since Q1 2020, across 26 quarterly 13F filings. ABT is 0.4% of Arrowstreet Capital's reported 13F portfolio.
Current Value
$988.8M
Current Shares
10.9M
Total Value Change
+$964M
Total Shares Change
+10.6M
Quarter-by-Quarter History
Other major holders of ABT: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC